Mehak Nogueira has a diverse work experience in the field of quality assurance and regulatory affairs. Currently, in 2022, they serve as the Director of Quality Assurance at BostonGene. Prior to this, from 2021 to 2022, they were the Associate Director of Quality Assurance and Regulatory Affairs at MedAcuity. Before that, they held roles at Tempus Labs, Inc. starting in 2018, where they served as a Senior Manager of Quality Assurance from February 2021 to May 2021, and previously as a Quality and Compliance Manager from May 2018 to January 2021. Mehak also gained experience at Foundation Medicine from 2014 to 2018, working as a Quality Assurance Associate from February 2016 to May 2018, and earlier as a Consultant/Client Services Representative from October 2014 to February 2016. Mehak began their career at Pri-Med in 2013 as an Educational Department Intern, where they worked until December 2013.
Mehak Nogueira, RAHP has an educational background in regulatory affairs and health policy. Mehak obtained a Master's Degree in Regulatory Affairs and Health Policy (RAHP) from MCPHS University between 2014 and 2016. Prior to that, they pursued a Bachelor of Science (BS) in Pharmaceutical Healthcare Business from the same institution, graduating between 2009 and 2014. Additionally, they have pursued further certifications to enhance their skills and expertise. In January 2020, they obtained the ISO 13485:2016 Internal Auditor certification from BSI. In July 2019, they completed the Good Clinical Practice Certificate of Completion from NIDA Clinical Trials Network.
Sign up to view 0 direct reports
Get started